GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD
Posted on December 12th, 201212/12/12
GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD. The goal of the new agreement is to develop a small-molecule-based medicine to potentially reverse FSHD
Filed under: FSHD Research